Cargando…

Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning

INTRODUCTION: Recent studies have reported that HbA1c and lipid variability is useful for risk stratification in diabetes mellitus. The present study evaluated the predictive value of the baseline, subsequent mean of at least three measurements and variability of HbA1c and lipids for adverse outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sharen, Zhou, Jiandong, Wong, Wing Tak, Liu, Tong, Wu, William K. K., Wong, Ian Chi Kei, Zhang, Qingpeng, Tse, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097996/
https://www.ncbi.nlm.nih.gov/pubmed/33947391
http://dx.doi.org/10.1186/s12902-021-00751-4
_version_ 1783688423287029760
author Lee, Sharen
Zhou, Jiandong
Wong, Wing Tak
Liu, Tong
Wu, William K. K.
Wong, Ian Chi Kei
Zhang, Qingpeng
Tse, Gary
author_facet Lee, Sharen
Zhou, Jiandong
Wong, Wing Tak
Liu, Tong
Wu, William K. K.
Wong, Ian Chi Kei
Zhang, Qingpeng
Tse, Gary
author_sort Lee, Sharen
collection PubMed
description INTRODUCTION: Recent studies have reported that HbA1c and lipid variability is useful for risk stratification in diabetes mellitus. The present study evaluated the predictive value of the baseline, subsequent mean of at least three measurements and variability of HbA1c and lipids for adverse outcomes. METHODS: This retrospective cohort study consists of type 1 and type 2 diabetic patients who were prescribed insulin at outpatient clinics of Hong Kong public hospitals, from 1st January to 31st December 2009. Standard deviation (SD) and coefficient of variation were used to measure the variability of HbA1c, total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglyceride. The primary outcome is all-cause mortality. Secondary outcomes were diabetes-related complications. RESULT: The study consists of 25,186 patients (mean age = 63.0, interquartile range [IQR] of age = 15.1 years, male = 50%). HbA1c and lipid value and variability were significant predictors of all-cause mortality. Higher HbA1c and lipid variability measures were associated with increased risks of neurological, ophthalmological and renal complications, as well as incident dementia, osteoporosis, peripheral vascular disease, ischemic heart disease, atrial fibrillation and heart failure (p <  0.05). Significant association was found between hypoglycemic frequency (p <  0.0001), HbA1c (p <  0.0001) and lipid variability against baseline neutrophil-lymphocyte ratio (NLR). CONCLUSION: Raised variability in HbA1c and lipid parameters are associated with an elevated risk in both diabetic complications and all-cause mortality. The association between hypoglycemic frequency, baseline NLR, and both HbA1c and lipid variability implicate a role for inflammation in mediating adverse outcomes in diabetes, but this should be explored further in future studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12902-021-00751-4.
format Online
Article
Text
id pubmed-8097996
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80979962021-05-06 Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning Lee, Sharen Zhou, Jiandong Wong, Wing Tak Liu, Tong Wu, William K. K. Wong, Ian Chi Kei Zhang, Qingpeng Tse, Gary BMC Endocr Disord Research INTRODUCTION: Recent studies have reported that HbA1c and lipid variability is useful for risk stratification in diabetes mellitus. The present study evaluated the predictive value of the baseline, subsequent mean of at least three measurements and variability of HbA1c and lipids for adverse outcomes. METHODS: This retrospective cohort study consists of type 1 and type 2 diabetic patients who were prescribed insulin at outpatient clinics of Hong Kong public hospitals, from 1st January to 31st December 2009. Standard deviation (SD) and coefficient of variation were used to measure the variability of HbA1c, total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglyceride. The primary outcome is all-cause mortality. Secondary outcomes were diabetes-related complications. RESULT: The study consists of 25,186 patients (mean age = 63.0, interquartile range [IQR] of age = 15.1 years, male = 50%). HbA1c and lipid value and variability were significant predictors of all-cause mortality. Higher HbA1c and lipid variability measures were associated with increased risks of neurological, ophthalmological and renal complications, as well as incident dementia, osteoporosis, peripheral vascular disease, ischemic heart disease, atrial fibrillation and heart failure (p <  0.05). Significant association was found between hypoglycemic frequency (p <  0.0001), HbA1c (p <  0.0001) and lipid variability against baseline neutrophil-lymphocyte ratio (NLR). CONCLUSION: Raised variability in HbA1c and lipid parameters are associated with an elevated risk in both diabetic complications and all-cause mortality. The association between hypoglycemic frequency, baseline NLR, and both HbA1c and lipid variability implicate a role for inflammation in mediating adverse outcomes in diabetes, but this should be explored further in future studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12902-021-00751-4. BioMed Central 2021-05-04 /pmc/articles/PMC8097996/ /pubmed/33947391 http://dx.doi.org/10.1186/s12902-021-00751-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lee, Sharen
Zhou, Jiandong
Wong, Wing Tak
Liu, Tong
Wu, William K. K.
Wong, Ian Chi Kei
Zhang, Qingpeng
Tse, Gary
Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning
title Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning
title_full Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning
title_fullStr Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning
title_full_unstemmed Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning
title_short Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning
title_sort glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097996/
https://www.ncbi.nlm.nih.gov/pubmed/33947391
http://dx.doi.org/10.1186/s12902-021-00751-4
work_keys_str_mv AT leesharen glycemicandlipidvariabilityforpredictingcomplicationsandmortalityindiabetesmellitususingmachinelearning
AT zhoujiandong glycemicandlipidvariabilityforpredictingcomplicationsandmortalityindiabetesmellitususingmachinelearning
AT wongwingtak glycemicandlipidvariabilityforpredictingcomplicationsandmortalityindiabetesmellitususingmachinelearning
AT liutong glycemicandlipidvariabilityforpredictingcomplicationsandmortalityindiabetesmellitususingmachinelearning
AT wuwilliamkk glycemicandlipidvariabilityforpredictingcomplicationsandmortalityindiabetesmellitususingmachinelearning
AT wongianchikei glycemicandlipidvariabilityforpredictingcomplicationsandmortalityindiabetesmellitususingmachinelearning
AT zhangqingpeng glycemicandlipidvariabilityforpredictingcomplicationsandmortalityindiabetesmellitususingmachinelearning
AT tsegary glycemicandlipidvariabilityforpredictingcomplicationsandmortalityindiabetesmellitususingmachinelearning